New York Oncology Hematology — New York, New York

New York Oncology Hematology is a clinical research site located in New York, New York, United States 12208.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

New York Oncology Hematology has participated in 2 clinical trials.

Therapeutic areas: Small Cell Lung Cancer, Non-small Cell Lung Cancer, Metastatic Breast Cancer.

Sponsors: Mersana Therapeutics, Janssen Diagnostics, LLC.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Oncology Hematology?

New York Oncology Hematology has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Oncology Hematology conducted?

New York Oncology Hematology has 2 clinical trials on record. Their work covers Small Cell Lung Cancer, Non-small Cell Lung Cancer, Metastatic Breast Cancer.

Is New York Oncology Hematology accredited by Crixeo Health?

New York Oncology Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Oncology Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.